These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9121763

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ret receptor tyrosine kinase activates extracellular signal-regulated kinase 2 in SK-N-MC cells.
    van Weering DH, Medema JP, van Puijenbroek A, Burgering BM, Baas PD, Bos JL.
    Oncogene; 1995 Dec 07; 11(11):2207-14. PubMed ID: 8570170
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differences in signal transduction pathways by which platelet-derived and fibroblast growth factors activate extracellular signal-regulated kinase in differentiating oligodendrocytes.
    Yim SH, Hammer JA, Quarles RH.
    J Neurochem; 2001 Mar 07; 76(6):1925-34. PubMed ID: 11259511
    [Abstract] [Full Text] [Related]

  • 5. Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival.
    De Vita G, Melillo RM, Carlomagno F, Visconti R, Castellone MD, Bellacosa A, Billaud M, Fusco A, Tsichlis PN, Santoro M.
    Cancer Res; 2000 Jul 15; 60(14):3727-31. PubMed ID: 10919641
    [Abstract] [Full Text] [Related]

  • 6. Cellular effects and antitumor activity of RET inhibitor RPI-1 on MEN2A-associated medullary thyroid carcinoma.
    Cuccuru G, Lanzi C, Cassinelli G, Pratesi G, Tortoreto M, Petrangolini G, Seregni E, Martinetti A, Laccabue D, Zanchi C, Zunino F.
    J Natl Cancer Inst; 2004 Jul 07; 96(13):1006-14. PubMed ID: 15240784
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ret-mediated mitogenesis requires Src kinase activity.
    Melillo RM, Barone MV, Lupoli G, Cirafici AM, Carlomagno F, Visconti R, Matoskova B, Di Fiore PP, Vecchio G, Fusco A, Santoro M.
    Cancer Res; 1999 Mar 01; 59(5):1120-6. PubMed ID: 10070972
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of Ret oncogene activity by the protein tyrosine phosphatase SHP1.
    Hennige AM, Lammers R, Höppner W, Arlt D, Strack V, Teichmann R, Machicao F, Ullrich A, Häring HU, Kellerer M.
    Endocrinology; 2001 Oct 01; 142(10):4441-7. PubMed ID: 11564708
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. RET-familial medullary thyroid carcinoma mutants Y791F and S891A activate a Src/JAK/STAT3 pathway, independent of glial cell line-derived neurotrophic factor.
    Plaza Menacho I, Koster R, van der Sloot AM, Quax WJ, Osinga J, van der Sluis T, Hollema H, Burzynski GM, Gimm O, Buys CH, Eggen BJ, Hofstra RM.
    Cancer Res; 2005 Mar 01; 65(5):1729-37. PubMed ID: 15753368
    [Abstract] [Full Text] [Related]

  • 14. RET activation by germline MEN2A and MEN2B mutations.
    Borrello MG, Smith DP, Pasini B, Bongarzone I, Greco A, Lorenzo MJ, Arighi E, Miranda C, Eng C, Alberti L.
    Oncogene; 1995 Dec 07; 11(11):2419-27. PubMed ID: 8570194
    [Abstract] [Full Text] [Related]

  • 15. Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma.
    Drosten M, Hilken G, Böckmann M, Rödicker F, Mise N, Cranston AN, Dahmen U, Ponder BA, Pützer BM.
    J Natl Cancer Inst; 2004 Aug 18; 96(16):1231-9. PubMed ID: 15316058
    [Abstract] [Full Text] [Related]

  • 16. Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation.
    Klint P, Kanda S, Kloog Y, Claesson-Welsh L.
    Oncogene; 1999 Jun 03; 18(22):3354-64. PubMed ID: 10362356
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
    Newberry EP, Willis D, Latifi T, Boudreaux JM, Towler DA.
    Mol Endocrinol; 1997 Jul 03; 11(8):1129-44. PubMed ID: 9212060
    [Abstract] [Full Text] [Related]

  • 19. Characterization of Ret-Shc-Grb2 complex induced by GDNF, MEN 2A, and MEN 2B mutations.
    Ohiwa M, Murakami H, Iwashita T, Asai N, Iwata Y, Imai T, Funahashi H, Takagi H, Takahashi M.
    Biochem Biophys Res Commun; 1997 Aug 28; 237(3):747-51. PubMed ID: 9299438
    [Abstract] [Full Text] [Related]

  • 20. Post-transcriptional silencing of RET occurs, but is not required, during raf-1 mediated differentiation of medullary thyroid carcinoma cells.
    Carson-Walter EB, Smith DP, Ponder BA, Baylin SB, Nelkin BD.
    Oncogene; 1998 Jul 23; 17(3):367-76. PubMed ID: 9690518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.